Stablecoin Development Corporation (SDEV)
NYSEAMERICAN: SDEV · Real-Time Price · USD
1.630
+0.100 (6.54%)
May 8, 2026, 4:00 PM EDT - Market closed
Stablecoin Development Revenue
Stablecoin Development had revenue of $-521.00K in the quarter ending December 31, 2025.
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
81.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.46M | -3.95M | -27.42% |
| Dec 31, 2022 | 14.40M | 4.20M | 41.16% |
| Dec 31, 2021 | 10.20M | 270.00K | 2.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AMTD IDEA Group | 88.47M |
| BCP Investment | 61.15M |
| Great Elm Capital | 47.04M |
| OFS Capital | 39.30M |
| Hennessy Advisors | 33.01M |
| The Marygold Companies | 28.85M |
| PhenixFIN | 24.89M |
| Great Elm Group | 22.83M |
SDEV News
- 4 weeks ago - Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV” - GlobeNewsWire
- 6 weeks ago - NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - GlobeNewsWire
- 2 months ago - Stablecoin Development Transcript: EGM 2026 - Transcripts
- 7 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 8 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 9 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 9 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 1 year ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire